The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period.
To know about the assumptions considered for the study download the pdf brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962
The growth in this market is mainly driven by the growing demand for disposable pre-packed columns, increasing demand for therapeutic antibodies, and the increasing pharmaceutical R&D spending are expected to drive the growth of this market during the forecast period.
Global Protein A Resin Market Scope:
|
Metrics |
Details |
|
Study Period |
2020–2025 |
|
Market Size in 2025 |
USD 1.9 Billion |
|
Segment Covered |
Product, Type, Application, End User, and Region |
|
by Type Covered |
Recombinant Protein A, Natural Protein A |
|
by product Covered |
High Efficiency Particulate Air (HEPA), Electrostatic Precipitators, Activated Carbon, Ultraviolet |
|
By Application Covered |
Antibody Purification, Immunoprecipitation |
|
Regions Covered |
North America, Europe, Asia Pacific, Middle East and Africa, and South America |
|
Key Players Profiled |
GE Healthcare (US), Merck Millipore (Germany), Repligen Corporation (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), Purolite Corporation (US), Novasep Holding SAS (France), Agilent Technologies (US), GenScript Biotech Corporation (China), PerkinElmer (US) |
GE Healthactre (US) is one of the the leading players in the global protein A resin market. The company has a vast sales network in North America, Asia, and Europe. Its strong sales network, along with strategies such as new product launches, investments, and agreements, are driving the company’s growth in the protein A resin market. GE Healthcare is one of the frontrunners in the resins business and caters to a diverse range of application segments. The company is also focusing on expanding its protein A resins business in the APAC region.
Repligen Corporation (US) is another one of the major players in the protein A resin market. Repligen’s merger with Spectrum, Inc. (US) in 2017 strengthened its position in the filtration market, where its existing products are used in upstream and downstream mAb production.
Merck Millipore (Germany)., another major vendor of Protein A resin. The company is a leading provider of chromatography consumables across the globe. It primarily focuses on expansions and new product launches as its key growth strategies to expand its presence in the global market.
Click Here to Access a Free Sample Report of the Global Protein A Resin Market @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=19196962
Recent Developments
· Merck Millipore (Germany) opened a new manufacturing and distribution center in India for its Life Science business.
· Repligen Corporation (US) merged with Spectrum Inc. (US), a leader in membrane separation technologies for the pharmaceutical, bioprocess, diagnostic, and research industries. This merger was aimed at accelerating the growth of its filtration business and enhancing its position as a leading developer of single-use and continuous manufacturing technologies for bioprocessing.
Our Free Sample Report Consists of the following:
· Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
· The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
· About 220+ Pages Research Report (Including Recent Research)
· Provide detailed chapter-by-chapter guidance on Request
· Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
· Includes Tables and figures have been updated
· The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
Directly Purchase a copy of the report [140] @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=19196962
